Bringing together over 300 industry and academic experts working in areas such as molecular biology/diagnostics, gene expression, genomics, biomarkers, pathogen detection, GMO, mRNA, NGS, bioinformatics and data management, the congress will examine the latest developments, opportunities and applications of both dPCR and qPCR through case studies across diverse areas such as oncology, virology, infectious diseases, vaccines, prenatal diagnosis, clinical applications, microbiology, food microbiology, plant/ecology genomics and other novel applications.
With increasing numbers of real-time PCR users purchasing digital PCR due to its reduction in cost, absolute quantification, improved sensitivity, precision and greater robustness; and with the gene amplification market predicted to grow to $2.2 billion by 2017, this conference provides a timely opportunity to learn first-hand about applications and guidelines in dPCR whilst also keeping up to date with latest developments and strategies in qPCR.
With increasing numbers of real-time PCR users purchasing digital PCR due to its reduction in cost, absolute quantification, improved sensitivity, precision and greater robustness; and with the gene amplification market predicted to grow to $2.2 billion by 2017, this conference provides a timely opportunity to learn first-hand about applications and guidelines in dPCR whilst also keeping up to date with latest developments and strategies in qPCR.
